|  Help  |  About  |  Contact Us

Publication : Anti-inflammatory actions of Syk inhibitors in macrophages involve non-specific inhibition of toll-like receptors-mediated JNK signaling pathway.

First Author  Lin YC Year  2010
Journal  Mol Immunol Volume  47
Issue  7-8 Pages  1569-78
PubMed ID  20138367 Mgi Jnum  J:160648
Mgi Id  MGI:4454759 Doi  10.1016/j.molimm.2010.01.008
Citation  Lin YC, et al. (2010) Anti-inflammatory actions of Syk inhibitors in macrophages involve non-specific inhibition of toll-like receptors-mediated JNK signaling pathway. Mol Immunol 47(7-8):1569-78
abstractText  Toll-like receptors (TLRs) are a major family of pattern recognition receptors (PRRs) and play a crucial role in innate immune system. Even though non-receptor spleen tyrosine kinase (Syk) is a key signaling molecule of immunoreceptor tyrosine-based activation motifs-containing immunoreceptors, its role in TLRs signaling is not clearly understood. Herein, we investigated the role of Syk in TLR-mediated signaling and gene regulation. In bone marrow-derived macrophages (BMDMs) and RAW 264.7 macrophages, treatment of poly(I:C), LPS and CpG, which are specific ligands of TLR3, TLR4 and TLR9, respectively, can increase the mRNA levels of several pro-inflammatory cytokines and mediators, including IFNbeta, TNFalpha, MIP2, IL-6, IL-12beta, iNOS and COX-2. The gene upregulation caused by TLR was inhibited by Syk inhibitor (SykI) and JNK inhibitor (SP600125). Accordingly we found the abilities of TLR3, TLR4 and TLR9 ligands to induce Syk and JNK activation, as evidenced by increased Syk autophosphorylation on Y519/Y520, JNK phosphorylation and both kinase activities. We also found that TLRs-mediated JNK activation, but not IKK, p38 and ERK activation as well as IkappaB degradation in BMDM and RAW 264.7 cells, was blocked by SykI. Nevertheless TLR-mediated JNK activation as well as the increased protein expression of iNOS and COX-2 remained unchanged when Syk protein was knockdown by siRNA approach. With in vitro kinase assay we found two commercial Syk inhibitors (SykI, and BAY61-3606) have direct inhibition on JNK activity. These findings demonstrate that the non-selective action of SykI on JNK should be taken into consideration upon using them to explore the biological actions of Syk.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

4 Authors

1 Bio Entities

Trail: Publication

0 Expression